###begin article-title 0
The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 488 496 488 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Dystroglycan (Dg) is a transmembrane protein that is a part of the Dystrophin Glycoprotein Complex (DGC) which connects the extracellular matrix to the actin cytoskeleton. The C-terminal end of Dg contains a number of putative SH3, SH2 and WW domain binding sites. The most C-terminal PPXY motif has been established as a binding site for Dystrophin (Dys) WW-domain. However, our previous studies indicate that both Dystroglycan PPXY motives, WWbsI and WWbsII can bind Dystrophin protein in vitro.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 365 372 365 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 446 456 446 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 472 478 <span type="species:ncbi:9606">humans</span>
We now find that both WW binding sites are important for maintaining full Dg function in the establishment of oocyte polarity in Drosophila. If either WW binding site is mutated, the Dg protein can still be active. However, simultaneous mutations in both WW binding sites abolish the Dg activities in both overexpression and loss-of-function oocyte polarity assays in vivo. Additionally, sequence comparisons of WW binding sites in 12 species of Drosophila, as well as in humans, reveal a high level of conservation. This preservation throughout evolution supports the idea that both WW binding sites are functionally required.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Based on the obtained results we propose that the presence of the two WW binding sites in Dystroglycan secures the essential interaction between Dg and Dys and might further provide additional regulation for the cytoskeletal interactions of this complex.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
The Dystroglycan-Dystrophin (Dg-Dys) complex has been shown to provide cells with structural integrity by forming a conduit between the extracellular matrix and the cytoskeletal network and there are lines of evidence that implicate an additional signaling role for the complex [1,2] Dystroglycan binds to extracellular matrix components, including Laminin at its N-terminus and the actin cytoskeleton via Dystrophin at its C-terminus [3,4] Defects in these interactions can result in muscular dystrophies (MD) and various epithelial cancers [5]
###end p 9
###begin p 10
###xml 69 80 69 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 459 470 459 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 681 692 681 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 733 738 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#948;</italic>
###xml 752 754 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 815 826 811 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 846 848 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 849 851 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 191 197 <span type="species:ncbi:9606">humans</span>
The characterization of the Dystrophin Glycoprotein Complex (DGC) in Drosophila has revealed that it possesses similar roles in muscle integrity and neuronal migration in flies as it does in humans [6] These abnormalities include age dependent muscle degeneration, reduced mobility, defects in eye development as manifested by altered photoreceptor axon path finding and photoreceptor morphology. Additionally, mutations in Dys and Dg affect cell polarity in Drosophila [6-8] Interestingly, some of these phenotypes are affected by the nutrition or energy metabolism in the animals [9] Recently, a reduced lifespan, as well as heart and muscle abnormalities, have been reported in Drosophila mutants of another component of the DGC, delta-sarcoglycan [10] and heart and further eye phenotypes have been observed in Drosophila Dys and Dg mutants [11,12]
###end p 10
###begin p 11
###xml 94 105 94 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 216 224 216 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 540 551 540 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 731 740 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 816 827 816 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 851 859 851 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 82 88 <span type="species:ncbi:9606">humans</span>
Analogous defects observed when the Dg-Dys complex is disturbed in both flies and humans make Drosophila an attractive model for further studies on clarifying the cellular function of the DGC. Recent biochemical and in vivo structure-function analyses have revealed that a specific set of C-terminal domains are critical for the function of Dystroglycan. We have found that a putative SH3 domain binding motif but, surprisingly, not the most C-terminal Dystrophin WW domain binding motif is required for Dg function in cellular polarity in Drosophila [13]. However, since two potential WW binding sites exist near the Dg C-terminus it is possible that the second WW binding site can also bind Dystrophin in vivo, as has been shown in vitro [13]. In this study we dissect the roles of the two WW binding sites in the Drosophila Dystroglycan C-terminus in vivo and, interestingly, find that the sites are essential and their functions are partially overlapping.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 188 198 188 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 645 656 645 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 659 668 659 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 846 856 846 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1149 1158 1149 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1159 1161 1159 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1338 1348 1338 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 623 629 <span type="species:ncbi:9606">humans</span>
In order to understand the regulation of Dg and its role in signaling, we have analyzed the binding motifs that are required for the function of the Dg-Dys complex in cellular polarity in Drosophila. The proline-rich C-terminus of Dg has several potential protein binding motifs, which suggests that it may be involved in regulating the complex and potentially may have signaling role(s). Proline-rich sequences have been shown to be the targets of several protein interaction domains involved in signal transduction. The most C-terminal PPxY motif has been established as a binding site for the WW domain of Dystrophin in humans [14-16] and in Drosophila by in vitro binding studies [6]. However, this WW domain binding site at the very C-terminus of Dystroglycan, is not essential for the function of the Dg-Dys complex in cellular polarity in Drosophila. An internal region of the Dystroglycan C-terminus containing a second WW domain binding site and a putative SH3 domain binding site appear to be sufficient for function in this context. We have also shown that Dystrophin can bind both the C-terminal and the internal WW domain binding sites in vitro [13]. We now test whether the internal WW domain binding site is essential, whether the two WW domain binding sites are redundant or whether neither is required for Dg function in Drosophila. To distinguish between these possibilities we used both overexpression and loss-of-function rescue analyses.
###end p 13
###begin title 14
Generation of transgenic lines expressing biochemically verified WWbs mutations
###end title 14
###begin p 15
###xml 144 153 144 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 939 940 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 979 990 968 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Previous results show that two mutations designed from computer predictions resulted in dramatic alterations in the affinity between Dg and Dys in vitro [13] These two mutations, predicted to abolish the WW but not the SH3 binding domain, resulted in very low binding affinities between the Dystroglycan C-terminal peptide and the Dystrophin WW domain with EF-hand region (DmWWbsI-W: Kd = 178 muM and DmWWbsII-G: Kd = 147 muM), as compared to wild type peptides (DmWWbsI: Kd = 16 muM and DmWWbsII: Kd = 46 muM). These values are comparable to the dissociation constant observed with a negative control for the assay (p53: Kd = 248 muM), suggesting that specific binding is abolished. We therefore generated transgenic lines expressing the following representative mutations: PPSG, which has a mismatch in WWbsII (PPSY --> PPSG) and 2WW, which has mutations in both WW binding sites (WWbsI, PPPY --> WAPY and WWbsII, PPSY --> PPSG) (Figure 1). At least two independent transgenic Drosophila lines for each construct were obtained and analyzed. Similar results with two independent transgenic lines confirmed that the phenotype was due to the Dg mutation and not due to positional effects of the transgene inserts.
###end p 15
###begin p 16
###xml 0 175 0 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transgenic constructs with mutations of WW binding sites at the Dystroglycan C-terminal end. Schematic drawing of pUASp constructs with mutations in different WW binding sites</bold>
Transgenic constructs with mutations of WW binding sites at the Dystroglycan C-terminal end. Schematic drawing of pUASp constructs with mutations in different WW binding sites. FL - construct which encodes full length Dg, 2WW - constructs with mutations in both WW binding sites, PPSG - mutation in the N-terminal WW binding motif WWbsII PPSY --> PPSG. C1 - deletion of the proline-rich C-terminus.
###end p 16
###begin p 17
###xml 113 122 113 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gal4/UAS </italic>
###xml 210 225 210 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFlp; actinFRT</italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD2</italic>
###xml 230 242 230 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRTGal4/UAS </italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 549 554 549 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 633 644 633 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MatTubGal4 </italic>
###xml 648 658 648 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanosGal4 </italic>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 794 805 794 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MatTubGal4 </italic>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 934 944 934 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanosGAl4 </italic>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1245 1246 1245 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1266 1267 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1287 1288 1287 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
We first tested the ability of the transgenic constructs to produce functional forms of the Dg protein using the Gal4/UAS system. In order to overexpress the transgenic constructs in follicle cells we used the hsFlp; actinFRT<CD2>FRTGal4/UAS system in which clonal cells that overexpress the gene of interest were marked with GFP. Dg, in the wild type follicular epithelium, is located at the basal membrane (Figure 2C; WT). Overexpression of the transgenes resulted in Dg localizing to both the apical and basal sides of the follicle cells (Figure 2A, B). We also tested the expression of the constructs in germline cells using the MatTubGal4 and nanosGal4 drivers. During oogenesis, Dg is expressed at low levels in the germline (Figure 2C; WT). At stage 2-3 of oogenesis overexpression with MatTubGal4 shows Dg levels are substantially increased in germline cells (Figure 2C). Increased protein levels were also observed using the nanosGAl4 driver which showed a distinct pattern starting with high levels in the germarium, lower levels during stages 3-6 and with higher levels during later stages (Figure 2C). Similar patterns and levels of the Dg constructs were observed with all the transgenic lines analyzed in these experiments (Figure 2, Additional Figure 1, Additional Figure 4).
###end p 17
###begin p 18
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of Dg constructs with mutation in WW binding sites in follicle and germline cells</bold>
###xml 98 102 98 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, B</bold>
Overexpression of Dg constructs with mutation in WW binding sites in follicle and germline cells. A, B. Overexpression of 2WW (A) and PPSG (B) constructs in follicle cells marked by GFP. Dg in the wild type cells is expressed at the apical side of the follicle cell epithelium, in contrast to overexpression where Dg is localized in both apical and basal sides (indicated by arrows). C. Overexpression of the constructs in the germline cells.wt - Dg expression in wild type germline cells, MatTubGal4;pUASp-PPSG, nanosGal4/pUASp-PPSG - overexpression of transgenic constructs in germline cells. Both MatTub- and nanosGal4 have distinct expression patterns.
###end p 18
###begin title 19
WW binding site function as assayed by oocyte polarity
###end title 19
###begin p 20
###xml 174 184 174 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MatTubGal4</italic>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 408 419 408 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
To analyze whether the Dg mutant forms are functional in oocyte polarity, we expressed mutant and wild type Dg constructs in germline cells using a germline specific driver (MatTubGal4), and examined oocyte polarity using Orb protein as a marker. Orb is a member of the cytoplasmic polyadenylation element binding (CPEB) family of RNA-binding proteins that are implicated in local protein synthesis [17]. In Drosophila oogenesis Orb co-localizes with the microtubule organizing center (MTOC), which is localized to the anterior of the oocyte during stage 1, and then moves to the posterior by stage 3. Between stages 3 and 6, Orb is clearly localized to the posterior of the oocyte, making it an excellent marker to analyze the polarity of the oocyte (Figure 3A, 4A). Absent or mislocalized Orb during these stages indicates a failure to establish early oocyte polarity.
###end p 20
###begin p 21
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of pUASp with MatTubGal4 in germline disrupts the polarity marker Orb</bold>
Overexpression of pUASp with MatTubGal4 in germline disrupts the polarity marker Orb. (Orb-red, Dg-green, DAPI - blue, separate channels for Orb are shown on the side of each corresponding picture). A. wild type (wt) stage 4 egg chamber shows normal Orb (red) localization at the posterior side of the oocyte. B. Overexpression of the pUASp-FL transgenic construct disrupts the normal Orb localization. C. Overexpression of the pUASp-2WW does not disrupt normal Orb (red) localization. Similar phenotype is seen with C1-construct that lacks the entire C-terminal region of Dg (D; Fig. 1). E. Overexpression of pUASp-PPSG constructs disrupts oocyte polarity indicated by mislocalization of Orb which has an abnormal side location, F. Percentage of Orb mislocalization as the result of overexpression of different pUASp-Dg constructs. (FL, 49 +/- 2, PPSG 44 +/- 2, 2WW 19 +/- 2, C1 16 +/- 3).
###end p 21
###begin p 22
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rescue of Dg loss-of-function germline clones with expression of pUASp-Dg constructs</bold>
###xml 394 410 394 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFLP; FRT42D Dg</italic>
###xml 410 413 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323</sup>
###xml 527 536 527 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pUASp-FL </italic>
###xml 724 740 724 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFLP; FRT42D Dg</italic>
###xml 740 743 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323</sup>
###xml 743 782 743 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">; P(w+:nanosGal4:VP-16)Ab-2/pUASp-FL) C</italic>
###xml 817 828 817 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanos-Gal4 </italic>
###xml 838 841 838 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg </italic>
###xml 979 995 979 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFLP; FRT42D Dg</italic>
###xml 995 998 995 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323</sup>
###xml 998 1035 998 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">; P(w+:nanosGal4:VP-16)Ab-2/pUASp-2WW</italic>
###xml 1038 1039 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1055 1066 1055 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pUASp-PPSG </italic>
###xml 1075 1086 1075 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanos-Gal4 </italic>
###xml 1096 1099 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg </italic>
###xml 1237 1253 1237 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFLP; FRT42D Dg</italic>
###xml 1253 1256 1253 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323</sup>
###xml 1256 1294 1256 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">; P(w+:nanosGal4:VP-16)Ab-2/pUASp-PPSG</italic>
###xml 1296 1297 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1359 1396 1359 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P(w+:nanosGal4:VP-16)Ab-2/pUASp-FL) F</italic>
Rescue of Dg loss-of-function germline clones with expression of pUASp-Dg constructs. Orb (Red); GFP (Green), DAPI (Blue) A', B', D' GFP of the corresponding stages shown in a separate channel; A", B", D" Orb staining of the corresponding stages shown in a separate channel with dotted lines which indicates the border of the oocyte. A. Dg loss-of-function germline clones (black, white arrow; hsFLP; FRT42D Dg323) are arrested prior to stage 6 and have disrupted oocyte polarity (absent or mislocalized Orb). B. Expression of pUASp-FL with the nanos-Gal4 driver in Dg clones partially rescues oocyte polarity in arrested clones stages 3-6 as indicated by proper localization of Orb to the posterior of 36% of the oocytes; (hsFLP; FRT42D Dg323; P(w+:nanosGal4:VP-16)Ab-2/pUASp-FL) C. Expression of pUASp-2WW with the nanos-Gal4 driver in Dg clones does not rescues oocyte polarity in arrested clones stages 3-6 (arrow) [as indicated by development arrest and absent Orb marker; (hsFLP; FRT42D Dg323; P(w+:nanosGal4:VP-16)Ab-2/pUASp-2WW)] D. Expression of pUASp-PPSG with the nanos-Gal4 driver in Dg clones rescues oocyte polarity in arrested clones stages 3-6 [as indicated by proper localization of Orb to the posterior of the oocyte; (hsFLP; FRT42D Dg323; P(w+:nanosGal4:VP-16)Ab-2/pUASp-PPSG)]E. Wild type egg chamber with posterior Orb localization (+/+; P(w+:nanosGal4:VP-16)Ab-2/pUASp-FL) F. FL, PPSG are able to rescue Dg loss-of-function phenotypes, while 2WW and C1 do not (Red: rescued polarity index, Green: rescued growth index).
###end p 22
###begin p 23
###xml 70 81 70 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 552 560 552 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tubGal4 </italic>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
We have previously shown that overexpression of the wild type form of Drosophila Dystroglycan (FL = full length) is sufficient to generate oocyte polarity defects [13] (Figure 3B). When FL is overexpressed in the germline, Orb becomes mislocalized, surrounds the entire oocyte nucleus, or accumulates in a clump to one side of the oocyte instead of localizing to the posterior. Therefore, Dystroglycan, when expressed at elevated levels in germline cells, is sufficient to disrupt oocyte polarity. Overexpression of the full length form of Dg with the tubGal4 driver causes semi-lethality (data not shown). Similarly, in vertebrates overexpression of Dg has been shown to cause defects in neuromuscular junctions [18,19]. We used the overexpression oocyte polarity assays to test whether either of the WW domain binding sites is essential for Dystroglycan function.
###end p 23
###begin p 24
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 107 118 107 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MatTubGal4 </italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 625 629 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E&#8211;F</xref>
###xml 711 712 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 713 715 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 763 764 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 773 778 771 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B, D</xref>
To test the function of WWbsI in vivo we overexpressed the PPSG mutant protein in germline cells using the MatTubGal4 driver and determined the localization of the early oocyte polarity marker Orb. As discussed, in wild type cells Orb marks the localization of the microtubule organizing center and is localized to the posterior side of the oocyte during stages 3-6 (Figure 3A). Overproduction of the PPSG protein results in the mislocalization of the usually posterior Orb marker. In mutants Orb surrounds the oocyte nucleus or localizes to the sides of the oocyte nucleus in 44 +/- 2% of 3-6 stage oocytes (n = 147, Figure 3E-F). The level of this defect is similar to the one observed with the FL construct [6,13], which contains both WW binding sites (Figure 1; Figure 3B, D; 49 +/- 2%, n = 80). These data suggest that disturbing the second WW binding site at the Dg C-terminus does not dramatically affect the functionality of the protein; similar to FL construct, when overexpressed it still is sufficient to disturb the oocyte polarity.
###end p 24
###begin p 25
###xml 151 156 151 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C, F</xref>
###xml 277 279 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 477 478 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 487 492 485 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D, F</xref>
In contrast to the FL and PPSG constructs, overexpression of a 2WW mutant construct did not result in a high percentage of Orb mislocalization (Figure 3C, F, 19 +/- 3%, n = 123). With 2WW overexpression, Orb, in most cases, was localized to the posterior of the oocyte (Figure 3C). The frequency of mislocalization with the 2WW construct, in which both WW binding sites were mutated was similar to that of the C1 construct which lacked all the C-terminal binding sites (Figure 1, Figure 3D, F, 16 +/- 2%, n = 86).
###end p 25
###begin p 26
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
These data, in combination with our previous data [13] show that a single mutation in WWbsII or the lack of WWbsI does not result in dramatic defects in Dg activity in this sufficiency assay measuring the oocyte polarity. However, simultaneous mutations in both WW binding sites dramatically reduce the function of Dystroglycan in this assay.
###end p 26
###begin title 27
One WW binding site is required for Dystroglycan function
###end title 27
###begin p 28
###xml 147 149 147 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323 </sup>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 445 449 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323 </sup>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 870 880 870 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanosGal4 </italic>
###xml 1154 1155 1154 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1174 1176 1174 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 1176 1180 1176 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323 </sup>
###xml 1296 1307 1296 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 1554 1556 1554 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1684 1685 1684 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
We also tested the function of the WW binding site mutants in rescue experiments by expressing the transgenes in a Dg loss-of-function background. Dg323 germline mutant clones are arrested prior to stage 3-4 and have mislocalized or missing Orb protein (Figure 4A). We have previously shown that these defects are partially rescued by wild type (full-length) Dg expression [13] (Figure 4, 36-40% rescue). Full rescue is not expected since the Dg323 deletion also affects a newly described neighboring gene mRpl34 (Additional Figure 3) and recent data implies that the level of nutrients and energy metabolism in the animal may affect cellular polarity [9]. To test if our mutant constructs were capable of rescuing the developmental arrest and the defects in oocyte polarity on the same level as the Dg full-length construct, we expressed them using the germline driver nanosGal4 and calculated the percentage of loss-of-function clones with rescued growth and polarity. Using this assay we tested whether the Dg WWbs mutations were capable of a similar level of rescue as full-length Dg. If the Dg mutant with both WW binding sites mutated (2WW, Figure 1) could rescue the Dg323 phenotype in oocyte polarity at the same level as wild type Dg, we conclude that neither of the WW binding sites in Drosophila is required for Dg activity. On the other hand, if Dg with two WWbs mutations cannot rescue, we conclude that both or just the internal WW binding site is essential for Dg activity (we have already shown that the C-terminal WWbs is not essential [13]). As discussed above, to distinguish between these possibilities, we have generated a single mutation in WWbsII (PPSG, Figure 1) and will test whether this mutant still has the full length Dg activity in the loss-of-function rescue assays.
###end p 28
###begin p 29
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 200 205 200 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B-B"</xref>
###xml 224 229 224 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D-D"</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 536 538 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 700 702 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 712 713 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 826 828 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 896 898 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 967 969 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
Similar to the full length Dg (FL, Figure 4B), the PPSG mutant constructs were capable of partially rescuing the Dg mutant phenotype (Figure 4D). Loss-of-function clones with expression of FL (Figure 4B-B") and PPSG (Figure 4D-D") had similar levels of posterior localization of the polarity marker, Orb (Figure 4F, FL: 36 +/- 0.5% n = 52; PPSG: 41% n = 22). These mutants were also capable of restoring the developmental arrest phenotype by showing a higher percentage of loss-of-function clones that were older than stage 4-6 (Figure 4F, FL: 47 +/- 8% n = 55; PPSG 38% n = 21). In contrast, 2WW was unable to rescue (2WW rescued at the level of the C1 mutant that lacks most of the Dg C-terminus; [13]; Figure 1.). Dg loss-of-function clones with expression of 2WW and C1 showed lower percentages of normal polarity (Figure 4F; 2WW: 12 +/- 0.6% n = 66; C1: 9% n = 22) and growth rescue (Figure 4F; 2WW: 19 +/- 2% n = 66; C1: 13%) than FL or PPSG constructs (Figure 4F). This result indicates that at least one WW binding site is required for normal function of Dg but a mutation in only one of the sites does not alter the functionality of Dg protein dramatically.
###end p 29
###begin p 30
Since a single WWbsII mutation or a WWbsI deletion does not cause a severe loss of Dg activity but the double mutant does, we conclude that the two binding sites act, at least partially in a redundant manner in oocyte polarity and growth assays.
###end p 30
###begin title 31
WW binding sites are highly conserved
###end title 31
###begin p 32
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 299 310 299 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 380 393 380 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 424 435 424 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 567 578 567 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 856 867 856 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 871 877 <span type="species:ncbi:9606">humans</span>
Since both WW binding sites proved to be important in our in vivo experiments we wanted to know if the importance of these sites has been preserved among the interspecies population. To analyze the conservation of WW binding sites, we tested for variability in the sequence of those sites among all Drosophila species. For this purpose, using the ClustalW program, we aligned the Dystroglycan sequences of the 12 species of Drosophila obtained from the GBrowse database. The alignment analysis indicates that the two WW binding sites are fully conserved among all 12 Drosophila species (Figure 5A). Some variation in the nucleotide sequences of the WW binding sites were observed between the species, however these changes did not lead to amino acid sequence changes (Additional Figure 2). Furthermore, both Dg WW binding sites were also conserved between Drosophila and humans (Figure 5B).
###end p 32
###begin p 33
###xml 57 67 57 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Both WW binding sites are conserved in all 12 species of <italic>Drosophila</italic></bold>
###xml 143 154 143 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 316 326 316 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 305 311 <span type="species:ncbi:9606">humans</span>
Both WW binding sites are conserved in all 12 species of Drosophila. A. Amino acid sequence alignment of the C-terminal end from 12 species of Drosophila using the computer program ClustalW shows absolutely no variation between both WW binding sites. B. Both WW binding sites are highly conserved between humans and Drosophila.
###end p 33
###begin p 34
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DAG</italic>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 583 585 583 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 749 751 749 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DAG </italic>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
In order to better understand patterns of polymorphisms in human Dystroglycan (DAG), and, in particular, the WW domains, we sequenced a 348 bp fragment spanning the region of interest in 88 samples from six geographically diverse human populations. In total, only one segregating site was identified among the 176 chromosomes sequenced (table 1) and none were identified in either of the WW domains. The estimated nucleotide diversity (defined as the average number of pairwise differences between two randomly selected chromosomes per nucleotide) in the combined sample is 3.24 x 10-5. In contrast, the average nucleotide diversity of 322 genetic regions that were sequenced in a panel of 23 European-Americans and 22 African-Americans is 8.53 x 10-4, suggesting that the sequenced region of DAG is under significant functional constraint. These data suggest that during evolution both WW binding sites have been important and therefore are preserved among species.
###end p 34
###begin p 35
Summary statistics of sequencing data.
###end p 35
###begin p 36
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a Number of chromosomes
###end p 36
###begin p 37
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b Number of segregating sites
###end p 37
###begin p 38
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
c Watterston's theta per bp
###end p 38
###begin p 39
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
d Nucleotide diversity per bp
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 486 490 <span type="species:ncbi:10090">mice</span>
The functional redundancy of the WW binding sites poses interesting questions: have both binding sites survived through evolution to protect organisms from the mutations in an essential complex or does each binding site have a specific function in different tissues and/or developmental stages. Mutations in the DGC cause muscular dystrophies; however only mutations in Dystrophin, but not Dystroglycan per se, are associated with known types of muscular dystrophies in vertebrates. In mice, mutations in Dystroglycan are embryonic lethal, which suggests that Dg is an essential gene and, perhaps the redundant Dystrophin binding sites in Dystroglycan provide an additional means for DGC regulation.
###end p 41
###begin p 42
###xml 37 48 37 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
The comparative sequence analysis of Drosophila and human WW binding motifs revealed very high conservation. However, each WWbs resides in a specific protein micro-environment, which may suggest that each site has specific binding partners. The previously performed genetic screens for modifiers [20] of Dg and Dys showed that the Dg-Dys complex interacts with components of different signaling pathways and components involved in cell/neuronal migration, cytoskeletal rearrangement and muscle development. This suggests that the Dg-Dys complex might be a major hub that regulates transfer of extracellular information to the cytoskeleton. Therefore it will be important in the future to test if WW binding sites have specific and independent biological functions in different tissues. This kind of analysis is likely to provide insights into the specific functions of the Dg-Dys complex and serve as a basis for the development of novel therapeutic approaches for the treatment of muscular dystrophy.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 264 272 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 342 350 342 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 897 905 891 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
We have investigated the role of the WW binding sites at the C-terminus of Dystroglycan protein and found that both sites may bind to the WW+EF hand domain of Dystrophin. Our previous studies [6,13], indicate that WWbsI and WWbsII both can bind Dystrophin protein in vitro. To test whether both WW binding sites can function and are required in vivo we generated two transgenic mutants: 2WW, which has mutations in both WW binding sites (WWbsI, PPPY --> WAPY and WWbsII, PPSY --> PPSG), and PPSG, which has a mismatch in WWbsII (PPSY --> PPSG). We used the establishment of early oocyte polarity as an assay to verify the functionality of WWbsI and WWbsII. Importantly, the data show that while each WW binding site mutation yields to close to normal Dg function, the double WWbs mutation has lost Dg C-terminal activity. These data suggest that at least one WWbs is required for full Dg function in vivo and that the two sites may be partially redundant.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Fly Stocks
###end title 46
###begin p 47
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster </italic>
###xml 168 173 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NGT40</italic>
###xml 175 176 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 177 178 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">w</italic>
###xml 178 179 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 180 189 174 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanosGal4</italic>
###xml 190 195 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VP-16</italic>
###xml 196 201 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab-2 </italic>
###xml 202 204 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 205 207 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 213 216 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mat</italic>
###xml 222 241 212 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4-TubGal4-VP16/CyO </italic>
###xml 242 244 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 309 349 299 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFlp; act &lt; FRT-CD2-FRT &lt; Gal4; UAS-GFP</italic>
###xml 350 352 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 373 386 363 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 402 411 392 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRT42D-Dg</italic>
###xml 411 414 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323</sup>
###xml 414 419 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/CyO </italic>
###xml 420 422 410 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 422 426 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323 </sup>
###xml 431 444 421 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 533 534 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 612 613 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 619 643 609 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFLP;FRT42D Ubi-GFP/CyO</italic>
###xml 681 694 671 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 721 730 711 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRT42D-Dg</italic>
###xml 734 740 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO; P</italic>
###xml 741 751 731 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">w nos-Gal4</italic>
###xml 752 756 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VP16</italic>
###xml 757 765 747 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4-2 III</italic>
###xml 771 811 761 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFLP; FRT42D Ubi-GFP/CyO; pUASp-Dg/TM3 </italic>
###xml 835 848 825 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 901 914 891 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 928 930 918 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 930 934 920 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink">248 </sup>
###xml 1001 1004 991 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg </italic>
###xml 1099 1101 1089 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 1101 1105 1091 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323 </sup>
###xml 1172 1175 1162 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg </italic>
###xml 1267 1268 1257 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1292 1294 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 0 23 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 64 69 <span type="species:ncbi:4932">yeast</span>
Drosophila melanogaster stocks were raised on standard cornmeal/yeast/agar medium at 25degreesC. For overproduction of pUASp-Dg in the germline, we used the following: NGT40; P(w+:nanosGal4:VP-16)Ab-2 [21,22] and Mat-alpha4-TubGal4-VP16/CyO [23]. For overproduction of pUASp-Dg in the follicle cells, we used hsFlp; act < FRT-CD2-FRT < Gal4; UAS-GFP[24]. For generation of Dystroglycan clones, we used FRT42D-Dg323/CyO (Dg323 is a Dystroglycan loss-of-function mutant with a 3324 bp deletion between bp 32,345 and 35,669 of DS03910 [7] disrupting the Dg 5' region and the adjacent mRPL34 gene; Additional Figure 3) and hsFLP;FRT42D Ubi-GFP/CyO. For overproduction of pUASp-Dg in a Dystroglycan mutant background, we used FRT42D-Dg323/CyO; P(w nos-Gal4:VP16)A4-2 III, and hsFLP; FRT42D Ubi-GFP/CyO; pUASp-Dg/TM3 (pUASp-Dg refers to all Dystroglycan constructs: FL, C1, 2WW, PPSG). Two deletions in the Dystroglycan region exist; Dg248 (11985709:11986494) whose breakpoints are 333 bp downstream of the Dg transcription start site (11986042) and 3 bp upstream of the mRpL34 start codon (11986498) and Dg323 (11983340:11986664) whose breakpoints are 2.7 kb downstream of the Dg transcription start site and 166 bp downstream of the mRpL34 start codon (Additional Figure 3). We also used: dg043 [25].
###end p 47
###begin title 48
Generation of pUASp-Dg Transgenic Animal
###end title 48
###begin p 49
###xml 25 38 25 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Full length and modified Dystroglycan PCR products that can be expressed in the germline were synthesized from the template LD11619. pUASp-FL and pUASp-C1 constructs used in this work have been described previously [13]. To generate a construct with mutated WWbsII (pUASp-PPSG) LD11619 was used as a template with the following primers: 5'-GGGGTACCAACATGAGATTCCAGTGGTTCT-3' 5'-GCTCTAGATTATGGCGACACACATA-TGGCGGT-3'. The PCR products were digested with KpnI and XbaI and cloned into the pUASp vector [26]. The constructs were injected into embryos to obtain at least two independent stable transformant lines. Injections were done by Rainbow Transgenic Flies, Inc. (California, USA).
###end p 49
###begin title 50
Overproduction of Dystroglycan in the Germline and Follicle Cell
###end title 50
###begin p 51
###xml 47 59 47 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pUASp-Dg/Mat</italic>
###xml 65 88 61 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4-TubGal4-UP16/CyO or P</italic>
###xml 89 90 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">w</italic>
###xml 90 91 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 93 102 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nanosGal4</italic>
###xml 103 108 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VP-16</italic>
###xml 109 114 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ab-2 </italic>
###xml 250 269 240 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsFlp; UAS-GFP act </italic>
###xml 270 280 260 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRTCD2FRT </italic>
###xml 281 295 271 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gal4/pUASp-Dg </italic>
For overproduction in germline cells, balanced pUASp-Dg/Mat-alpha4-TubGal4-UP16/CyO or P(w-: nanosGal4:VP-16)Ab-2 animals were raised in yeasted vials at 25degreesC for 3 days before dissection and analysis. For overproduction in the follicle cells, hsFlp; UAS-GFP act <FRTCD2FRT <Gal4/pUASp-Dg animals were heat-shocked at 37degreesC for 1 h, raised in yeasted vials at 25degreesC for 3 days before dissection and analysis. All pUASp-Dg constructs used were crossed to these three Gal4 drivers to test for proper overproduction of protein and correct localization of protein to the membrane in the germline and somatic cells. The following pUASp-Dg lines were used for germline analysis: FL-1, 5; C1-1, -2; 2WW-10.2, -5.6, -13, 15.4; PPSG-11.1, -12.5, -6.3, -13.4. For the rescue experiments the following lines were used: FL-1, -2, -5; C1-1, -2; 2WW-10.4, -13, -15.6; PPSG-11.4, 11.1.
###end p 51
###begin title 52
Antibody Staining Procedures
###end title 52
###begin p 53
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 255 261 <span type="species:ncbi:9986">rabbit</span>
###xml 294 299 <span type="species:ncbi:10090">mouse</span>
###xml 444 450 <span type="species:ncbi:9986">rabbit</span>
###xml 470 475 <span type="species:ncbi:10090">mouse</span>
Drosophila ovaries were dissected rapidly in PBS and fixed in 4% paraformaldehyde for 10 minutes. The antibody staining procedure was the same as described previously [13]. The following primary antibodies were used at the following designated dilutions: rabbit anti-Dystroglycan (1:3000 [7]), mouse anti-Orb (1:20; Developmental Studies Hybridoma Bank), the following secondary antibodies were used at the designated dilutions: Alexa 488 anti-rabbit and Alexa 568 anti-mouse (1:500; Molecular Probes).
###end p 53
###begin title 54
Western Blot and densitometry analyses
###end title 54
###begin p 55
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 357 361 <span type="species:ncbi:9925">Goat</span>
###xml 367 373 <span type="species:ncbi:9986">rabbit</span>
Sample preparation and SDS-PAGE have been described previously [13]. Bio-Rad ready-made 4-20% polyacrylamide gels were used for protein separation. Proteins were transferred to polyvinylidene difluoride (PDVF) membranes (Immobilon) using a semi-dry transfer apparatus (Bio-Rad). Primary affinity purified anti-Dg antibodies were used at 1:30,000 dilutions. Goat anti-rabbit HRP conjugated antibodies (Bio-Rad) were used as detection reagents at 1:10,000 dilutions. Proteins were visualized via enhanced chemiluminescence (Millipore). Densitometry analysis was performed with the public domain NIH IMAGEJ program (developed at the US National Institutes of Health and available on the Web at ). Scans of immunoblots determined to be in the linear range (i.e. twice the amount of protein correlated with twice the signal seen on photographic film) were used as sources for analysis.
###end p 55
###begin title 56
Sequence alignment
###end title 56
###begin p 57
###xml 27 38 27 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Sequences of 12 species of Drosophila were obtained from the FlyBase genome database. Sequence alignment was done using software ClustalW designed by the European Bioinformatics Institute .
###end p 57
###begin title 58
DNA samples used for sequencing
###end title 58
###begin p 59
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DAG </italic>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 91 97 <span type="species:ncbi:9606">humans</span>
We sequenced a 348 bp fragment of DAG that includes both WW domains in DNA samples from 88 humans representing six populations. Samples were obtained from the Coriell Institute for Medical Research Cell Repositories (Camden, NJ, USA). Coriell repository numbers for these samples are as follows: CEPH European-American (NA06990, NA07019, NA10830, NA10831, NA07348, NA07349, NA10842, NA10843, NA10844, NA10845, NA10848, NA10850, NA10851, NA10852, NA10853, NA10854, NA10857, NA10858, NA10860, NA10861, NA17201) Han Chinese of L.A. (NA17733 - NA17747, NA17749, NA17752 - NA17757, NA17759, and NA17761), Middle East (NA17041 - NA17050), Pygmy (NA10469 - NA10473, NA10492 - NA10496), South Africa (NA17319, NA17341 - NA17348), South America (NA17301 - NA17310) and South East Asia (NA17081 - NA17090). We compared patterns of polymorphism to 322 genes that were sequenced as part of the SeattleSNPs project [27].
###end p 59
###begin title 60
DNA sequencing and statistical analysis
###end title 60
###begin p 61
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 540 542 536 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">W </sub>
###xml 590 592 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Sequencing primers were designed with primer3 (; primer sequences available upon request). We used standard PCR-based sequencing reactions using Applied Biosystem's Big Dye sequencing protocol on an ABI 3130xl. Sequence data was assembled using Phred/Phrap [28,29] and the alignments were inspected for accuracy with Consed [30,31]. Polymorphisms were identified with PolyPhred 4.0 [32]. All polymorphic sites were manually verified and confirmed by sequencing the opposite strand. Standard measures of nucleotide diversity, including thetaW and pi were calculated as previously described [27].
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
ASY conception, design, acquisition, analysis and interpretation of the data, drafting the manuscript. MMK conception, design, acquisition, analysis and interpretation of the data. HRS drafting the manuscript. MP conception, design, acquisition, analysis and interpretation of the data, revising the manuscript. KAF acquisition, analysis and interpretation of the data. JM acquisition, analysis and interpretation of the data. WMD conception and interpretation of the data. MS conception and interpretation of the data. SB conception and interpretation of the data. JA conception, design and interpretation of the data, drafting the manuscript. HRB conception, design and interpretation of the data, drafting the manuscript. All the authors have read the article and accepted the final manuscript.
###end p 63
###begin title 64
Supplementary Material
###end title 64
###begin title 65
Additional file 1
###end title 65
###begin p 66
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Figure 1</bold>
Figure 1. Overexpression of Dg constructs with mutation in WW binding sites in follicle and germline cells. A, B. Overexpression of 2WW (A) and PPSG (B) constructs in follicle cells marked by GFP. Dg in the wild type cells is expressed at the apical side of the follicle cell epithelium, in contrast to overexpression where Dg is localized in both apical and basal sides (indicated by arrows). To compare the expression levels of different constructs and insertions the intensities of Dg expression was compared to the intensity of the GFP signal in the same cell. The observed mean intensity ratios are similar in the two constructs (2WW = 1.2, PPSG = 1.1), suggesting that the differences observed between these two conatructs in oocyte polarity assay are not due to dramatically different levels of expression. C. Overexpression of the constructs in the germline cells.wt - Dg expression in wild type germline cells, MatTubGal4; pUASp-WW, nanosGal4/pUASp-WW - overexpression of transgenic constructs in germline cells. Both MatTub- and nanosGal4 have distinct expression patterns.
###end p 66
###begin p 67
Click here for file
###end p 67
###begin title 68
Additional file 4
###end title 68
###begin p 69
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Figure 4</bold>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Figure 4. Western blot analysis of Dg protein in wild type, DgO43, 2WW and PPSG ovaries and whole animals show the following Dg intensities compared to OregonR (WT): DgO43 [25] = 0.4, 2WW = 1.3, PPSG = 1.2. The specific bands that correspond to different Dg forms can be seen at ~180 (two bands), 110 and faintly at 70 kD. A presumable degradation product can be seen below 25 kD. Increased band intensities can be seen with the 110 kD band and most notably with the higher 180 kD species. Band intensities were normalized to actin and samples were run on a gradient 4-20% gel.
###end p 69
###begin p 70
Click here for file
###end p 70
###begin title 71
Additional file 3
###end title 71
###begin p 72
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Figure 3</bold>
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 99 112 99 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dystroglycan </italic>
###xml 127 129 127 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 129 133 129 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">323 </sup>
###xml 137 139 137 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dg</italic>
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">248 </sup>
Figure 3. The genomic region of the Dystroglycan gene. The genomic regions that are deleted in the Dystroglycan mutant alleles Dg323 and Dg248 are indicated as black bars.
###end p 72
###begin p 73
Click here for file
###end p 73
###begin title 74
Additional file 2
###end title 74
###begin p 75
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Figure 2</bold>
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Figure 2. Comparative analysis of Dg C-terminus nucleic acid sequences in 12 species of Drosophila.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Acknowledgements
###end title 77
###begin p 78
We thank members of the Ruohola-Baker lab for useful discussions and Dr. R. Ray for fly lines. This work was supported by an AHA fellowship for H.R.S., CRDF for A.S.Y., K.M.M., H.R.S. and H.R-B. and by the grants from the National Institute of Health and Muscular Dystrophy Association for H.R-B.
###end p 78
###begin article-title 79
Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction
###end article-title 79
###begin article-title 80
Binding of laminin alpha1-chain LG4-5 domain to alpha-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling
###end article-title 80
###begin article-title 81
Molecular mechanisms of muscular dystrophies: old and new players
###end article-title 81
###begin article-title 82
Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue
###end article-title 82
###begin article-title 83
###xml 51 56 <span type="species:ncbi:9606">human</span>
Dystroglycan: from biosynthesis to pathogenesis of human disease
###end article-title 83
###begin article-title 84
Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy
###end article-title 84
###begin article-title 85
Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila
###end article-title 85
###begin article-title 86
Cell-cell communication and axis specification in the Drosophila oocyte
###end article-title 86
###begin article-title 87
Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress
###end article-title 87
###begin article-title 88
Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants
###end article-title 88
###begin article-title 89
Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype
###end article-title 89
###begin article-title 90
###xml 58 81 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Temporal and spatial transcriptional profiles of aging in Drosophila melanogaster
###end article-title 90
###begin article-title 91
A putative Src homology 3 domain binding motif but not the C-terminal dystrophin WW domain binding motif is required for dystroglycan function in cellular polarity in Drosophila
###end article-title 91
###begin article-title 92
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan
###end article-title 92
###begin article-title 93
The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan
###end article-title 93
###begin article-title 94
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan
###end article-title 94
###begin article-title 95
Function of the Drosophila CPEB protein Orb2 in long-term courtship memory
###end article-title 95
###begin article-title 96
Dystroglycan overexpression in vivo alters acetylcholine receptor aggregation at the neuromuscular junction
###end article-title 96
###begin article-title 97
A role for the juxtamembrane domain of beta-dystroglycan in agrin-induced acetylcholine receptor clustering
###end article-title 97
###begin article-title 98
Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex
###end article-title 98
###begin article-title 99
Quantitative analysis of gene function in the Drosophila embryo
###end article-title 99
###begin article-title 100
Regulation of zygotic gene expression in Drosophila primordial germ cells
###end article-title 100
###begin article-title 101
DRhoGEF2 encodes a member of the Dbl family of oncogenes and controls cell shape changes during gastrulation in Drosophila
###end article-title 101
###begin article-title 102
Induction of Drosophila eye development by decapentaplegic
###end article-title 102
###begin article-title 103
The detached locus encodes Drosophila Dystrophin, which acts with other components of the Dystrophin Associated Protein Complex to influence intercellular signalling in developing wing veins
###end article-title 103
###begin article-title 104
Gal4 in the Drosophila female germline
###end article-title 104
###begin article-title 105
Population history and natural selection shape patterns of genetic variation in 132 genes
###end article-title 105
###begin article-title 106
Base-calling of automated sequencer traces using phred. I. Accuracy assessment
###end article-title 106
###begin article-title 107
Base-calling of automated sequencer traces using phred. II. Error probabilities
###end article-title 107
###begin article-title 108
Consed: a graphical tool for sequence finishing
###end article-title 108
###begin article-title 109
Automated finishing with autofinish
###end article-title 109
###begin article-title 110
Automating resequencing-based detection of insertion-deletion polymorphisms
###end article-title 110

